While some studies found no significant differences in TNF-alpha levels between autism and control groups [54], others demonstrated that interventions targeting TNF-alpha, such as valproic acid exposure in mice, could reduce neuroinflammation and improve behavioral outcomes [42,55]. This evidence concerns the gene TNF and autism.